Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Price:
748.87
USD
-2.47%
Market Closed
Market Cap:
$79.2B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
US |
|
Yankuang Energy Group Co Ltd
OTC:YZCHF
|
CN |
|
EastWest Bioscience Inc
XTSX:EAST
|
CA |
|
Poste Italiane SpA
OTC:PITAF
|
IT |
|
AI/ML Innovations Inc
OTC:AIMLF
|
CA |
|
A
|
Aegean Airlines SA
ATHEX:AEGN
|
GR |
|
Aemetis Inc
NASDAQ:AMTX
|
US |
|
R
|
Rovsing A/S
CSE:ROV
|
DK |
|
O
|
OVB Holding AG
SWB:O4B
|
DE |
|
Color Star Technology Co Ltd
NASDAQ:ADD
|
US |
|
N
|
NVIDIA Corp
BMV:NVDA
|
US |
|
Hotel Shilla Co Ltd
KRX:008770
|
KR |
|
C
|
Cloudbreak Discovery PLC
LSE:CDL
|
UK |
|
P
|
Publicis Groupe SA
OTC:PGPEF
|
FR |
|
Publity AG
XETRA:PBY
|
DE |
|
C
|
China Sandi Holdings Ltd
HKEX:910
|
HK |
|
Secom Co Ltd
TSE:9735
|
JP |
|
S
|
Sonel SA
WSE:SON
|
PL |
|
G
|
Go Metals Corp
OTC:GOCOF
|
CA |
|
L
|
Lytus Technologies Holdings Ptv Ltd
NASDAQ:LYT
|
IN |
|
China Finance Online Co Ltd
OTC:JRJCY
|
CN |
|
Fonu2 Inc
OTC:FONU
|
US |
|
Bowhead Specialty Holdings Inc
NYSE:BOW
|
US |
|
C
|
Cashbox Ventures Ltd
CNSX:CBOX.X
|
CA |
Multiples-Based Value
The Multiples-Based Value of one
REGN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 748.87 USD,
Regeneron Pharmaceuticals Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
REGN Multiples-Based Value
LOCKED
Multiples Across Competitors
REGN Competitors Multiples
Regeneron Pharmaceuticals Inc Competitors
Regeneron Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
367.6B USD | 6 | 87.8 | 14.6 | 20.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.2B USD | 5.1 | 24.5 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.5B USD | 5.9 | 20.3 | 12.7 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.8B USD | 9.2 | 28 | 21 | 22 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.2B EUR | 11.9 | 38.2 | 41.3 | 42.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.1B AUD | 3 | 32.9 | 11.1 | 13.9 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
42.6B USD | 11.5 | 135.9 | 75.7 | 84.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
